Geron

GERN

Geron Corporation is a biotechnology company located in Menlo Park, California, which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

Geron has been a target of short sellers for a while. The current short interest of 11.61% is roughly at the average of the last 12 months (11.47%).